Articles

Podcasts

Videos

The TMIOA Medical Director highlights the best sessions, new topics, and growing discussion around the 18th annual congress.

Yehuda Handelsman, MD: The World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease Preview

2020 was the year when regulators, clinicians, and patients had no choice but to embrace the concept of wearable monitoring devices. But it’s been a long time coming for the technology class.

Digital Cardiology: A New Frontier, A New Hope

Our annual series is touching on the stories in medicine that occurred during this unforgettable time.

Welcome to This Year in Medicine 2020

Pediatric patients who initiated insulin pump therapy within 6 months of diagnosis demonstrated better cardiovascular risk profiles than those who delayed treatment.


Early Use of Insulin Pump Therapy Beneficial for Children with Type 1 Diabetes

Largest study of multiple health indicators over time finds widening disparities in health by race, despite increased targeted funding.

Measuring Magnitude of Disparities in US Healthcare over Decades

Liquidia Technologies plans on addressing FDA concerns regarding treprostinil. 

FDA Issues CRL for Pulmonary Arterial Hypertension Inhalation Powder

Literature is scarce in identifying and characterizing risk of post-operative diabetes mellitus among patients with pancreatic cystic lesions.

Study Characterizes New Onset Diabetes Risk Following Partial Pancreatic Resection

More studies are planned testing the impact of finerenone.

George Bakris: The Future of Finerenone as a Diabetes Treatment

Finerenone could be another option to SGLT2 inhibitors for this patient population.

George Bakris, MD: Finerenone Showing Promise Treating Type 2 Diabetes

Researchers present new data from the SUSTAIN 6 and PIONEER 6 trials during the virtual AHA 2020 conference. 